U S Physical Therapy Inc /Nv (NYSE: USPH)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0000885978
Market Cap 1.51 Bn
P/B 2.99
P/E 33.71
P/S 1.99
ROIC (Qtr) 7.46
Div Yield % 2.79
Rev 1y % (Qtr) 17.32
Total Debt (Qtr) 308.40 Mn
Debt/Equity (Qtr) 0.61

About

U.S. Physical Therapy, Inc. (USPH) is a leading company in the healthcare industry, specializing in outpatient physical therapy services. With a history that spans over two decades, the company has established itself as a significant player in this sector. USPH operates through two main segments: physical therapy operations and industrial injury prevention services. The physical therapy operations segment is the backbone of USPH's business, accounting for about 95% of its revenue. This segment is run through subsidiary clinic partnerships, where...

Read more

Price action

Investment thesis

Bull case

  • Robust free cash flow of 56.90M exceeds capital expenditure of 12.63M by 4.50x, indicating strong organic growth funding capability.
  • Robust tangible asset base of 329.43M provides 14.11x coverage of working capital 23.36M, indicating strong operational backing.
  • Operating cash flow of 69.53M provides solid 0.60x coverage of current liabilities 115.08M, showing strong operational health.
  • Tangible assets of 329.43M provide robust 5.79x coverage of other current liabilities 56.90M, indicating strong asset backing.
  • Operating cash flow of 69.53M fully covers other non-current liabilities 41.11M by 1.69x, showing strong long-term stability.

Bear case

  • Operating cash flow of 69.53M barely covers its investment activities of (126.12M), with a coverage ratio of -0.55, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 69.53M provides thin coverage of dividend payments of (27.16M) with a -2.56 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Cash reserves of 31.10M provide limited coverage of acquisition spending of (114.80M), which is -0.27x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating cash flow of 69.53M barely covers operating expenses of (9.07M) with a -7.67 ratio, suggesting thin operational efficiency margins and limited flexibility.
  • Operating cash flow of 69.53M shows concerning coverage of minority interest expenses of 16.65M, which is 4.18x, suggesting complex corporate structure risks.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.48 1.26
EV to Cash from Ops. EV/CFO 25.50 12.78
EV to Debt EV to Debt 5.75 12.10
EV to EBIT EV/EBIT 24.06 10.74
EV to EBITDA EV/EBITDA 16.43 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 31.16 18.02
EV to Market Cap EV to Market Cap 1.18 432.64
EV to Revenue EV/Rev 2.34 2.77
Price to Book Value [P/B] P/B 2.98 -1.92
Price to Earnings [P/E] P/E 33.61 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 1.64 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 75.20 -13.44
Dividend per Basic Share Div per Share (Qtr) 1.79 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 47.82 5.42
Interest Coverage Int. cover (Qtr) 8.05 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -41.68 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -73.41 65.22
Dividend Growth (1y) % Div 1y % (Qtr) 2.29 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 79.93 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 81.11 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) 79.76 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) 95.44 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 170.45 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) -22.53 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 16.55 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.63 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.33 0.04
Cash Ratio Cash Ratio (Qtr) 0.27 0.39
Current Ratio Curr Ratio (Qtr) 1.20 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.61 -13.19
Interest Cover Ratio Int Coverage (Qtr) 8.05 -97.94
Times Interest Earned Times Interest Earned (Qtr) 8.05 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 12.80 -95.81
EBIT Margin % EBIT Margin % (Qtr) 9.71 -94.97
EBT Margin % EBT Margin % (Qtr) 8.50 -105.60
Gross Margin % Gross Margin % (Qtr) 18.70 23.31
Net Profit Margin % Net Margin % (Qtr) 5.90 -106.14